Drug Type Live biotherapeutic products |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Vaginosis | Phase 2 | - | 08 Jul 2024 | |
Candidiasis, Vulvovaginal | Phase 2 | - | 08 Jul 2024 | |
Infective vaginitis | Phase 2 | - | 08 Jul 2024 | |
Vaginitis | Phase 2 | - | - |